跳至主要内容
临床试验/NCT00841451
NCT00841451No Longer Available不适用

Pulmonary Vein Isolation Outcomes With Eicosapentaenoic Acid (EPA)and Docosahexaenoic Acid (DHA)

St. Luke's-Roosevelt Hospital Center3 个研究点 分布在 1 个国家开始时间: 2009年2月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
No Longer Available
试验地点
3

研究概览

简要总结

Fish oil therapy may decrease the incidence of cardiac arrhythmias. This study will test whether pre-treatment with fish oils before catheter ablation of atrial fibrillation decreases the early post operative occurrence of atrial fibrillation.

研究设计

研究类型
Expanded Access

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Paroxysmal Atrial fibrillation (PAF).
  • Persistent atrial fibrillation. Persistent AF is not self-limited.

排除标准

  • Previous pulmonary vein isolation ablation procedure
  • Contraindication for anticoagulation
  • Permanent AF
  • Severe valvular pathology
  • Concurrent use of antiarrhythmic medications
  • Inability to give consent
  • Pregnancy

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验